Educated Patient® Lung Cancer Summit Targeted Treatment Session: August 14, 2021

Mikela Pettigrew, B.S.N., RN, OCN,, exemplifies extraordinary compassion and dedication. Every day, she fulfills a promise she made as a young caregiver.

February brought in multiple FDA approvals in the oncology space. Here’s an overview of some of the most recent ones.

Kathleen Coughlin, although small in stature, is often referred to as the “Bulldozer.”

Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews

In patients with advanced squamous non–small cell lung cancer, ivonescimab plus chemo was associated with progression-free survival results.